119 related articles for article (PubMed ID: 3144890)
1. Cytotoxicity of mixed human monoclonal antibodies reacting to tumor antigens.
Hagiwara H; Aotsuka Y
Acta Paediatr Jpn; 1987 Aug; 29(4):552-6. PubMed ID: 3144890
[No Abstract] [Full Text] [Related]
2. Human monoclonal IgM antibodies from foetal B-cell hybridomas directed against a surface antigen on human tumour cells.
Bohn J; Josimovic-Alasevic O; Settmacher U; Kiessig ST; Lukowsky A; Volk HD; Diamantstein T; Von Baehr R; Jahn S
Res Immunol; 1992; 143(9):879-91. PubMed ID: 1289988
[TBL] [Abstract][Full Text] [Related]
3. Relevance for neurobiology and neurooncology of antigens of malignant gliomas as defined by monoclonal antibodies.
Vrionis FD; Wikstrand CJ; Bigner DD
Ann N Y Acad Sci; 1988; 540():64-77. PubMed ID: 2462837
[No Abstract] [Full Text] [Related]
4. Human glioma-specific antigens detected by monoclonal antibodies.
Kondo S; Miyatake S; Iwasaki K; Oda Y; Kikuchi H; Zu Y; Shamoto M; Namba Y
Neurosurgery; 1992 Apr; 30(4):506-11. PubMed ID: 1584348
[TBL] [Abstract][Full Text] [Related]
5. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens.
Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ
Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324
[No Abstract] [Full Text] [Related]
6. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
Woodhouse CS; Morgan AC
Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies reactive with human myeloid leukaemia cells.
Ball ED; Fanger MW
Clin Exp Immunol; 1982 Jun; 48(3):655-65. PubMed ID: 6956470
[TBL] [Abstract][Full Text] [Related]
8. [Cyto-destruction of leukemic blasts in vitro using a monoclonal antibody and complement].
Pérez-Oteyza J; Brieva JA; Odriozola J; Bootello A; Navarro JL
Sangre (Barc); 1986; 31(5):587-92. PubMed ID: 2949378
[No Abstract] [Full Text] [Related]
9. Monoclonal antibody mechanisms of action in cancer.
Weiner GJ
Immunol Res; 2007; 39(1-3):271-8. PubMed ID: 17917071
[TBL] [Abstract][Full Text] [Related]
10. Antibody dependent cellular cytotoxicity and complement mediated cytotoxicity on leukemic cells mediated by anti K562 monoclonal antibodies.
Tatake RJ; Maniar HS; Chiplunkar SV; Somasundaram R; Amin MK; Saikia T; Gangal SG
J Clin Lab Immunol; 1990 Feb; 31(2):87-91. PubMed ID: 1966990
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies with cytotoxic reactivities against human gliomas.
Nanda A; Liwnicz B; Atkinson BF; Sela BA; Takahashi H; Belser PH; Black P; Koprowski H; Herlyn D
J Neurosurg; 1989 Dec; 71(6):892-7. PubMed ID: 2585082
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of immunity in cancer.
Baldwin RW
Pathobiol Annu; 1981; 11():155-75. PubMed ID: 6460216
[No Abstract] [Full Text] [Related]
13. A dual-chamber system for screening cytotoxic effects of hybridoma-produced antibodies.
Long TT; Kalantarov G; Chudner A; Trakht I
Monoclon Antib Immunodiagn Immunother; 2013 Aug; 32(4):246-54. PubMed ID: 23909417
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells.
Cheung NK; Saarinen UM; Neely JE; Landmeier B; Donovan D; Coccia PF
Cancer Res; 1985 Jun; 45(6):2642-9. PubMed ID: 2580625
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a monoclonal antibody recognizing a 138 kDa glioblastoma-associated antigen.
Klaich GM; Kanter PM
Anticancer Drugs; 1995 Feb; 6(1):45-52. PubMed ID: 7756683
[TBL] [Abstract][Full Text] [Related]
16. Surface-epitope masking: a strategy for the development of monoclonal antibodies specific for molecules expressed on the cell surface.
Shen R; Su ZZ; Olsson CA; Goldstein NI; Fisher PB
J Natl Cancer Inst; 1994 Jan; 86(2):91-8. PubMed ID: 7505832
[TBL] [Abstract][Full Text] [Related]
17. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
Fogler WE; Klinger MR; Abraham KG; Gottlinger HG; Riethmuller G; Daddona PE
Cancer Res; 1988 Nov; 48(22):6303-8. PubMed ID: 2460221
[TBL] [Abstract][Full Text] [Related]
18. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
19. Human monoclonal antibodies.
Kan-Mitchell J; Mitchell MS
Prog Clin Biol Res; 1989; 288():85-94. PubMed ID: 2717643
[No Abstract] [Full Text] [Related]
20. A bispecific monoclonal antibody directed against both the membrane-bound complement regulator CD55 and the renal tumor-associated antigen G250 enhances C3 deposition and tumor cell lysis by complement.
Blok VT; Daha MR; Tijsma O; Harris CL; Morgan BP; Fleuren GJ; Gorter A
J Immunol; 1998 Apr; 160(7):3437-43. PubMed ID: 9531304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
